Amyloidosis Centre Success Story

Education

Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial

Nov 18, 2024

Chest pain and coronary artery disease in cardiac amyloidosis: Prevalence, mechanisms, and clinical implications

Nov 15, 2024

Abstract 4148214: Missing the Point: Readability Analysis of Online Patient Information for Cardiac Amyloidosis

Nov 11, 2024

Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatments

Nov 09, 2024

Increasing clinicians’ suspicion of ATTR amyloidosis using a retrospective algorithm

Nov 08, 2024

More in Education

Community Center

National Organization for Rare Disorders (NORD) Announces $85,000 in Grant Funding for Amyloidosis and Levy-Yeboa Syndrome

Sep 30, 2024

Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy

Sep 30, 2024

Noninvasive eye test can help diagnose hATTR at early stage

Sep 30, 2024

National Organization for Rare Disorders (NORD) Announces $85,000 in Grant Funding for Amyloidosis and Levy-Yeboa Syndrome

Sep 30, 2024

Serum Amyloid P Component as a Therapeutic Target in Amyloidosis

Sep 29, 2024

More in Community Center

News

AL Amyloidosis Market to Show Remarkable Growth Trends from 2024 to 2034, DelveInsight Reports | Janssen Pharma, Prothena, Alexion Pharma, Alnylam Pharma, Attralus, Neurimmune AG

Dec 06, 2024

Acoramidis Sustains Benefits in Patients With ATTR-CM in Open-Label Extension Study

Dec 06, 2024

BridgeBio Selects PANTHERx® Rare Specialty Pharmacy for Distribution of Attruby™ (acoramidis)

Nov 26, 2024

Look out, Pfizer: BridgeBio scores 'best-case' FDA nod for Attruby in cardiomyopathy

Nov 25, 2024

Acoramidis Snags FDA Approval for ATTR Cardiomyopathy

Nov 25, 2024

More in News

Hot Topics

When Chronic Illness Joins Your Marriage

Jul 14, 2024

Linking Changes in Quality of Life to Haematologic Response and Survival in Systemic Immunoglobulin Light-Chain Amyloidosis

Jan 28, 2023

Expert Consensus on Multidisciplinary Care for Cardiac Amyloidosis: 2023 ACC Report

Jan 22, 2023

CRISPR’s Quest to Slay Donegal Amy

Dec 28, 2022

Amyloid Nomenclature 2022: Update, Novel Proteins, and Recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee

Nov 23, 2022

Video